<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="51240">Propidium iodide</z:chebi> (PI) DNA distribution of bone marrow (BM) cells was studied by flow cytometry (FCM) in 36 patients without hematologic or malignant disease (<z:mpath ids='MPATH_458'>normal</z:mpath> BM) and in 172 patients with <z:hpo ids='HP_0001903'>anemias</z:hpo> (36 pts), <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) (33 pts) and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (AL) at diagnosis (60 pts), remission (24 pts) and relapse (19 pts) </plain></SENT>
<SENT sid="1" pm="."><plain>White blood cells from <z:mpath ids='MPATH_458'>normal</z:mpath> male subjects were used as an external diploid reference standard (median CV = 3.8) </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with <z:mpath ids='MPATH_458'>normal</z:mpath> BM, <z:hpo ids='HP_0001903'>anemias</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> at diagnosis had <z:chebi fb="0" ids="53526">tritiated thymidine</z:chebi> labeling index (LI) and most with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and AL had also evaluable cytogenetics performed on the same BM sample used for FCM </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> BM, median aliquot of cells with PI-DNA content intermediate between the diploid and the tetraploid value (2n-4n cells %) was 15.7 </plain></SENT>
<SENT sid="4" pm="."><plain>The ratio between the fluorescence intensity of the G0/1 peak of <z:mpath ids='MPATH_458'>normal</z:mpath> BM cells and the fluorescence intensity of the G0/1 peak of the reference standard (FI ratio) ranged from 93 to 1.05 (mean +/- 2SD) </plain></SENT>
<SENT sid="5" pm="."><plain>The 2n-4n cell % was higher than <z:mpath ids='MPATH_458'>normal</z:mpath> in <z:hpo ids='HP_0001903'>anemias</z:hpo> (p less than .001), lower in <z:hpo ids='HP_0001909'>leukemias</z:hpo> (p less than .001) and widely scattered in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>A linear correlation was found between 2n-4n cell % and LI, with 2n-4n cell % value higher than LI </plain></SENT>
<SENT sid="7" pm="."><plain>The FI ratio was lower than <z:mpath ids='MPATH_458'>normal</z:mpath> in <z:hpo ids='HP_0001903'>anemias</z:hpo> (p less than .05), higher in AL with <z:mpath ids='MPATH_458'>normal</z:mpath> cytogenetics (p less than .02) and broadly scattered in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:mpath ids='MPATH_458'>normal</z:mpath> cytogenetics </plain></SENT>
<SENT sid="8" pm="."><plain>From our experience, PI-DNA-FCM is a simple and adequate method to evaluate proliferative activity in <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Nevertheless, caution must be taken in attributing small changes in FI ratio to <z:mp ids='MP_0004024'>aneuploidy</z:mp>, since they are found in <z:hpo ids='HP_0001903'>anemias</z:hpo> and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and AL with <z:mpath ids='MPATH_458'>normal</z:mpath> cytogenetics, possibly due to differences in PI uptake by different cell types </plain></SENT>
</text></document>